{"disease":{"id":"invasive-ductal-breast-carcinoma","name":"invasive ductal breast carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01953588","title":"Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1473,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT04021069","title":"Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT04084730","title":"Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":280,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT01417286","title":"Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":true},{"nct_id":"NCT02779855","title":"Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT05837767","title":"A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue","phase":"NA","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT02186470","title":"Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03947151","title":"Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04185311","title":"Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT01706432","title":"Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT01960803","title":"Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}